CNS Therapeutics
portfoliocompanies
company snapshot
Founded by recognized leaders in intrathecal therapies, CNS Therapeutics developed and brought to market safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system. CNS was acquired by Covidien in 2012.
website
www.cnstherapeutics.comLeadership
Follow The Company
Recent News1
CNS gets FDA OK for first drug
November, 2010